Comparing written exposure therapy to Prolonged Exposure for the treatment of PTSD in a veteran sample: A non-inferiority randomized design

被引:11
|
作者
Sloan, Denise M. [1 ,2 ]
Marx, Brian P. [1 ,2 ]
Acierno, Ronald [3 ]
Messina, Michael [4 ]
Cole, Travis A. [1 ]
机构
[1] Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Univ Texas Hlth Sci Ctr Houston, Faillace Dept Psychiat, Houston, TX 77030 USA
[4] William S Middleton VA Med Ctr, Madison, WI USA
关键词
Clinical trial; Posttraumatic stress disorder; Exposure-based treatment; Military veterans; Trauma-focused treatment; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; IMAGINAL EXPOSURE; PSYCHOTHERAPY; TELEMEDICINE; METAANALYSIS; DEPRESSION; EFFICACY; WOMEN; TRIAL;
D O I
10.1016/j.conctc.2021.100764
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Posttraumatic stress disorder (PTSD) is highly prevalent among veterans. Although there are effective treatment approaches for PTSD, such as Prolonged Exposure (PE) and Cognitive Processing Therapy, many providers trained in these approaches do not use them, or use them without sufficient fidelity, and veterans drop out of these treatments at very high rates. The time intensive nature of these treatments is frequently cited as a barrier to receiving the treatment among veterans and delivering the treatment among providers. According, there is an urgent need to establish more efficient and effective PTSD treatment approaches in order to meet the needs of veterans seeking care. Written exposure therapy (WET) is an efficient, exposure-based treatment, and may represent a plausible alternative treatment option to address PTSD in veterans. Although WET has been found to be effective and non-inferior to more time intensive trauma-focused treatment, it has not yet been investigated with a veteran sample. In an ongoing randomized controlled trial (RCT) we are investigating whether WET is non-inferior in treating PTSD compared with the more time intensive PE. The study sample will include 150 men and women veterans diagnosed with PTSD who are randomly assigned to either WET (n = 75) or PE (n = 75). Participants are assessed prior to treatment and 10-, 20-, and 30-weeks after the first treatment session. The primary outcome is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Establishing that PTSD can be treated effectively with fewer treatment sessions would represent a significant advance in improving access to evidence-based care for veterans with PTSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Written exposure therapy and app-delivered mindfulness-based meditation for PTSD and subthreshold PTSD in China: Design of a randomized controlled trial
    Li, Muyang
    Wang, Bingsu
    Chen, Qiang
    Gao, Danlong
    Zang, Yinyin
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 22
  • [22] Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial
    Alexander Miloff
    Philip Lindner
    William Hamilton
    Lena Reuterskiöld
    Gerhard Andersson
    Per Carlbring
    Trials, 17
  • [23] Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial
    Miloff, Alexander
    Lindner, Philip
    Hamilton, William
    Reuterskiold, Lena
    Andersson, Gerhard
    Carlbring, Per
    TRIALS, 2016, 17
  • [24] Automated virtual reality exposure therapy for spider phobia vs. in-vivo one-session treatment: A randomized non-inferiority trial
    Miloff, Alexander
    Lindner, Philip
    Dafgard, Peter
    Deak, Stefan
    Garke, Maria
    Hamilton, William
    Heinsoo, Julia
    Kristoffersson, Glenn
    Rafi, Jonas
    Sindemark, Kerstin
    Sjolund, Jessica
    Zenger, Maria
    Reuterskiold, Lena
    Andersson, Gerhard
    Carlbring, Per
    BEHAVIOUR RESEARCH AND THERAPY, 2019, 118 : 130 - 140
  • [25] A non-inferiority trial of Prolonged Exposure for posttraumatic stress disorder: In person versus home-based telehealth
    Acierno, Ron
    Knapp, Rebecca
    Tuerk, Peter
    Gilmore, Amanda K.
    Lejuez, Carl
    Ruggiero, Kenneth
    Muzzy, Wendy
    Egede, Leonard
    Hernandez-Tejada, Melba A.
    Foa, Edna B.
    BEHAVIOUR RESEARCH AND THERAPY, 2017, 89 : 57 - 65
  • [26] Correction to: A brief intervention for PTSD versus treatment as usual: Study protocol for a non-inferiority randomized controlled trial
    Halvor Stavland
    Camilla Refvik
    Jarle Eid
    Rafiq Lockhat
    Åsa Hammar
    Trials, 22
  • [27] Comparing the effect of prolonged exposure therapy (PET) and metacognitive therapy (MCT) on the quality of life among veterans with PTSD
    Rahnejat, Amir Mohsen
    Ebrahimi, Mohammadreza
    Salimi, Seyed Hossein
    Fathi Ashtiani, Ali
    Taghva, Arsia
    Mohammadi, Tina
    Ghadam, Haleh Shahed Hagh
    Barzoki, Hassan Shahmiri
    MILITARY PSYCHOLOGY, 2024, 36 (04) : 422 - 430
  • [28] Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial
    Meshberg-Cohen, Sarah
    Cook, Joan M.
    Bin-Mahfouz, Amirah
    Petrakis, Ismene L.
    CONTEMPORARY CLINICAL TRIALS, 2024, 139
  • [29] Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: A randomized, pilot trial
    Baig, Muhammad R.
    Wilson, Jennifer L.
    Beck, Robert D.
    Lemmer, Jennifer A.
    Hernandez, Anna L.
    Meraj, Adeel
    Tapia, Rebecca N.
    Meyer, Eric C.
    Mintz, Jim
    Peterson, Alan L.
    Roache, John D.
    JOURNAL OF BEHAVIORAL AND COGNITIVE THERAPY, 2022, 32 (04) : 243 - 253
  • [30] Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol
    Shiroma, Paulo R.
    Thuras, Paul
    Polusny, Melissa A.
    Kehle-Forbes, Shannon
    Disner, Seth
    Pardo, Jose, V
    Gilmore, Casey
    Tolly, Brian
    Voller, Emily
    Mcmanus, Eliza
    King, Christie
    Lipinski, Alexandra
    Eng, Emily
    Hawkinson, Francine
    Wang, Gloria
    CONTEMPORARY CLINICAL TRIALS, 2024, 143